DR. JOHN YIANNI, CEO

PhD in Biophysics, Founder, CEO, Board member of several medical device companies (Biocompatibles, Thermocore, Reverse Medical); launched first coated coronary stent in EU (exit to Abbott); Founder and Board member Reverse medical (exit to Medtronic), Partner, Earlybird Venture Capital Health Fund.

SEBASTIEN COLLART, CFO

MSc in Political Science &  Business engineering, 15 years experience in finance within SMEs in start-up, scale-up or restructuring phases. Before joining Cryotherapeutics in 2021, spent some years in a start-up active in the Medtech industry at Kiomed Pharma.

DR. PIERRE DOUETTE, REGULATORY & STRATEGIC CONSULTANT

PhD Biochemistry & Masters in Management, 15 years in regulatory & clinical, quality & operations in medtech. Prior to joining led approval of two innovative Class III devices in orthopedics & dermatology at KiOmed Pharma. Previously manager in quality operations at Artialis, Eurogentec and GSK.

URSULA MORJARIA, VP CLINICAL AFFAIRS

BSc in Medical Biology and MBA, a seasoned clinical executive combining 20 years of experience in Medtech and Pharma, across startups (Metronom Health, Celyad/Cardio3 Biosciences) and large corporations (Medtronic, GE Healthcare). 


Board of Directors

Eric Brandt

Rainer Christine

Dr. Joachim Rautter

Karlheinz Schmelig

Dr. ARISTOTELIS NASTOS

ALFRED WONG

DR. MAURICE BUCHBINDER

 

Update

CryoTherapeutics closes new €12.3 million financing round.

Find out more